These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 813934)

  • 1. Mechanisms of specific and non-specific tumour immunity after azathioprine treatment of mice.
    Purves EC
    Clin Exp Immunol; 1975 Nov; 22(2):348-58. PubMed ID: 813934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. I. Phagocytic and non-phagocytic effector cell activity against erythrocyte and tumour target cells in a 51Cr release cytotoxicity assay and [125I]IUdR growth inhibition assay.
    Greenberg AH; Shen L; Medley G
    Immunology; 1975 Oct; 29(4):719-29. PubMed ID: 810417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relation between the T cells responsible for cell-mediated cytotoxic killing of mastocytoma cells and the helper-cell effect.
    Igarashi T; Okada M; Kishimoto S; Yamamura Y
    Immunology; 1975 Jan; 28(1):37-47. PubMed ID: 803916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice.
    Orsini F; Pavelic Z; Mihich E
    Cancer Res; 1977 Jun; 37(6):1719-26. PubMed ID: 66985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetic control of T cell-mediated immunity against the DBA/2 mastocytoma P-815. II. Low responsiveness in T cell-mediated cytotoxicity accompanied by the inability to produce antibodies in a secondary response.
    Kölsch E
    Eur J Immunol; 1975 Aug; 5(8):527-32. PubMed ID: 824139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity.
    Borel JF
    Immunology; 1976 Oct; 31(4):631-41. PubMed ID: 824198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-dependent cell-mediated cytotoxicity. Comparative ability of murine Peyer's patch and spleen cells to lyse lipopolysaccharide-coated and uncoated erythrocytes.
    Kagnoff MF; Campbell S
    Gastroenterology; 1976 Mar; 70(3):341-6. PubMed ID: 1082425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG; Good RA
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular and humoral immunity in tumour bearing animals immunized with erythrocytes.
    Donovan G; Dumitrescu R; Popp I; Maltezeanu G
    Neoplasma; 1971; 18(3):241-9. PubMed ID: 5093945
    [No Abstract]   [Full Text] [Related]  

  • 10. The interplay of lymphoid cells and macrophages in tumour immunity.
    Alexander P; Evans R; Grant CK
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):645-58. PubMed ID: 5050874
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of azathioprine on in vitro antibody response. Differential effect on B cells involved in thymus-dependent and independent responses.
    Galanaud P; Crevon MC; Dormont J
    Clin Exp Immunol; 1975 Oct; 22(1):139-52. PubMed ID: 1082392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levamisole augments the cytotoxic T-cell response depending on the dose of drugs and antigen administered.
    Faanes RB; Dillon P; Choi YS
    Clin Exp Immunol; 1977 Mar; 27(3):502-6. PubMed ID: 405166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of cyclophosphamide, 6-mercaptopurine, azathiopurine and methotrexate. Relative effects on the humoral and the cellular immune response in the mouse.
    Otterness IG; Chang YH
    Clin Exp Immunol; 1976 Nov; 26(2):346-54. PubMed ID: 991462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-dependent human lymphocytotoxicity: a micro assay system.
    Zeijlemaker WP; Roos MT; Schellekens PT; Eijsvoogel VP
    Eur J Immunol; 1975 Aug; 5(8):579-84. PubMed ID: 824141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. V. Spleen immunoreactivity and cell mediated cytotoxicity.
    Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
    Arch Geschwulstforsch; 1987; 57(4):265-74. PubMed ID: 3118852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of the development of immune responses of mice against allogeneic tumor cells after adriamycin treatment.
    Tomazic V; Ehrke MJ; Mihich E
    Cancer Res; 1981 Sep; 41(9 Pt 1):3370-6. PubMed ID: 7260903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunity during ampicillin administration against a background of immunosuppression].
    Sakaeva DD; Lazareva DN
    Eksp Klin Farmakol; 1998; 61(6):39-41. PubMed ID: 9929815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of age on cell-mediated immunity in long-lived mice.
    Goodman SA; Makinodan T
    Clin Exp Immunol; 1975 Mar; 19(3):533-42. PubMed ID: 812622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector mechanisms of cell-mediated immunity to xenogeneic cell antigens.
    Dennert G
    J Immunol; 1974 Jul; 113(1):201-8. PubMed ID: 4208918
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.